The potential of cell-based therapy in lung diseases

Expert Opinion on Biological Therapy

Volumn 13, Issue 10, 2013, Pages 1429-1440

  Huleihel, Luai ^a,b   Levine, Melanie ^a   Rojas, Mauricio ^a,c  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^b BEN GURION UNIVERSITY OF THE NEGEV   (Israel)

^c MCGOWAN INSTITUTE FOR REGENERATIVE MEDICINE   (United States)

Author keywords

Acute respiratory distress syndrome; Aging; Asthma; Chronic obstructive pulmonary diseases; Fibrosis; Idiopathic pulmonary fibrosis; Lung; Mesenchymal stem cells

Indexed keywords

ACETYL LOW DENSITY LIPOPROTEIN; ALPHA1 INTEGRIN; ALPHA5 INTEGRIN; ANGIOPOIETIN 1; BIOLOGICAL MARKER; BLEOMYCIN; CD133 ANTIGEN; CD34 ANTIGEN; CD4 ANTIGEN; FIBRONECTIN; GAMMA INTERFERON; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; INDOLEAMINE 2,3 DIOXYGENASE; INTERFERON; INTERLEUKIN 10; INTERLEUKIN 12; INTERLEUKIN 1ALPHA; INTERLEUKIN 1BETA; INTERLEUKIN 2; INTERLEUKIN 4; KERATINOCYTE GROWTH FACTOR; MICRORNA; NITRIC OXIDE; SCATTER FACTOR; STROMAL CELL DERIVED FACTOR 1; TRANSFORMING GROWTH FACTOR BETA; TRYPTOPHAN; TUMOR NECROSIS FACTOR ALPHA; VASCULOTROPIN; VASCULOTROPIN C;

ACUTE HEART INFARCTION; ADULT RESPIRATORY DISTRESS SYNDROME; AGING; ALLERGIC ASTHMA; ANGIOGENESIS; ARTIFICIAL VENTILATION; BRONCHIOLITIS OBLITERANS; CANCER GROWTH; CARDIOVASCULAR DISEASE; CELL FUNCTION; CELL THERAPY; CHRONIC LUNG DISEASE; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL TRIAL (TOPIC); CROHN DISEASE; EMBRYONIC STEM CELL; ENDOTHELIAL PROGENITOR CELL; FIBROSING ALVEOLITIS; GENE EXPRESSION; GRAFT VERSUS HOST REACTION; HUMAN; IN VITRO STUDY; IN VIVO STUDY; INTERSTITIAL LUNG DISEASE; LUNG ALVEOLUS EPITHELIUM; LUNG CANCER; LUNG TRANSPLANTATION; LYMPHOCYTE PROLIFERATION; MESENCHYMAL STEM CELL; NONHUMAN; PHASE 2 CLINICAL TRIAL (TOPIC); PLURIPOTENT STEM CELL; RANDOMIZED CONTROLLED TRIAL (TOPIC); REGULATORY T LYMPHOCYTE; REVIEW; SEPSIS; T LYMPHOCYTE; VASCULAR DISEASE;

ANIMALS; CELL- AND TISSUE-BASED THERAPY; HUMANS; LUNG DISEASES; MESENCHYMAL STEM CELL TRANSPLANTATION; MESENCHYMAL STROMAL CELLS;

EID: 84884252480     PISSN: 14712598     EISSN: None     Source Type: Journal    
DOI: 10.1517/14712598.2013.833603     Document Type: Review

References (98)

1. Friedenstein AJ, Chailakhyan RK, Latsinik NV, et al. Stromal cells responsible for transferring the microenvironment of the hemopoietic tissues: Cloning in vitro and retransplantation in vivo. Transplantation 1974;17(4):331-40
2. Iyer S, Co C, Rojas M. Mesenchymal stem cells and inflammatory lung diseases. Panminerva Med 2009;51(1):5
3. Dominici M, Le Blanc K, Mueller I, et al. Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement. Cytotherapy 2006;8(4):315-17
4. Rojas M, Xu J, Woods CR, et al. Bone marrow-derived mesenchymal stem cells in repair of the injured lung. Am J Respir Cell Mol Biol 2005;33(2):145-52
5. Ortiz LA, Gambelli F, McBride C, et al. Mesenchymal stem cell engraftment in lung is enhanced in response to bleomycin exposure and ameliorates its fibrotic effects. Proc Natl Acad Sci USA 2003;100(14):8407-11
6. Marusciac L, Panaitescu C, Paunescu V. Interactions between mesenchymal stem cells and cellular effectors of immune system. Fiziologia Physiol 2012;22(1):4-10
7. Gupta N, Su X, Popov B, et al. Intrapulmonary delivery of bone marrow-derived mesenchymal stem cells improves survival and attenuates endotoxin-induced acute lung injury in mice. J Immunol 2007;179(3):1855-63
8. Ortiz LA, DuTreil M, Fattman C, et al. Interleukin 1 receptor antagonist mediates the antiinflammatory and antifibrotic effect of mesenchymal stem cells during lung injury. Proc Natl Acad Sci 2007;104(26):11002-7
9. Jiang X-X, Zhang Y, Liu B, et al. Human mesenchymal stem cells inhibit differentiation and function of monocyte-derived dendritic cells. Blood 2005;105(10):4120-26
10. Akiyama K, Chen C, Wang D, et al. Mesenchymal-stem-cell-induced immunoregulation involves FAS-ligand-/ FAS-mediated T cell apoptosis. Cell Stem Cell 2012;10(5):544-55
11. Jarvinen L, Badri L, Wettlaufer S, et al. Lung resident mesenchymal stem cells isolated from human lung allografts inhibit T cell proliferation via a soluble mediator. J Immunol 2008;181(6):4389-96
12. Badri L, Walker NM, Ohtsuka T, et al. Epithelial interactions and local engraftment of lung-resident mesenchymal stem cells. Am J Respir Cell Mol Biol 2011;45(4):809-16
13. Sato K, Ozaki K, Oh I, et al. Nitric oxide plays a critical role in suppression of T-cell proliferation by mesenchymal stem cells. Blood 2007;109(1):228-34
14. Meisel R, Brockers S, Heseler K, et al. Human but not murine multipotent mesenchymal stromal cells exhibit broad-spectrum antimicrobial effector function mediated by indoleamine 2, 3-dioxygenase. Leukemia 2011;25(4):648-54
15. Le Blanc K, Tammik L, Sundberg B, et al. Mesenchymal stem cells inhibit and stimulate mixed lymphocyte cultures and mitogenic responses independently of the major histocompatibility complex. Scand J Immunol 2003;57(1):11-20
16. Le Blanc K, Tammik C, Rosendahl K, et al. HLA expression and immunologic propertiesof differentiated and undifferentiated mesenchymal stem cells. Exp Hematol 2003;31(10):890-6
17. Spees JL, Olson SD, Whitney MJ, Prockop DJ. Mitochondrial transfer between cells can rescue aerobic respiration. Proc Natl Acad Sci USA 2006;103(5):1283-8
18. Cho YM, Kim JH, Kim M, et al. Mesenchymal stem cells transfer mitochondria to the cells with virtually no mitochondrial function but not with pathogenic mtDNA mutations. PLoS One 2012;7(3):e32778
19. Islam MN, Das SR, Emin MT, et al. Mitochondrial transfer from bone-marrow-derived stromal cells to pulmonary alveoli protects against acute lung injury. Nat Med 2012;18(5):759-65
20. Vallabhaneni KC, Haller H, Dumler I. Vascular smooth muscle cells initiate proliferation of mesenchymal stem cells by mitochondrial transfer via tunneling nanotubes. Stem Cells Dev 2012;21(17):3104-13
21. da Silva Meirelles L, Fontes AM, Covas DT, Caplan AI. Mechanisms involved in the therapeutic properties of mesenchymal stem cells. Cytokine Growth Factor Rev 2009;20(5-6):419-27
22. Wang H, Yang Y-F, Zhao L, et al. Hepatocyte growth factor gene-modified mesenchymal stem cells reduce radiation-induced lung injury. Hum Gene Ther 2013;24(3):343-53
23. Lee JW, Fang X, Gupta N, et al. Allogeneic human mesenchymal stem cells for treatment of e. coli endotoxin-induced acute lung injury in the ex vivo perfused human lung. Proc Natl Acad Sci USA 2009;106(38):16357-62
24. Aguilar S, Scotton CJ, McNulty K, et al. Bone marrow stem cells expressing keratinocyte growth factor via an inducible lentivirus protects against bleomycin-induced pulmonary fibrosis. PLoS One 2009;4(11):e8013
25. Mei SHJ, McCarter SD, Yupu D, et al. Prevention of LPS-induced acute lung injury in mice by mesenchymal stem cells overexpressing angiopoietin 1. PLoS Med 2007;4(9):e269-1537
26. Giordano A, Galderisi U, Marino IR. From the laboratory bench to the patient's bedside: An update on clinical trials with mesenchymal stem cells. J Cell Physiol 2007;211(1):27-35
27. Ringdén O, Uzunel M, Rasmusson I, et al. Mesenchymal stem cells for treatment of therapy-resistant graft-versus-host disease. Transplantation 2006;81(10):1390-7
28. Hare JM, Traverse JH, Henry TD, et al. A randomized, double-blind, placebo-controlled, dose-escalation study of intravenous adult human mesenchymal stem cells (prochymal) after acute myocardial infarction. J Am Coll Cardiol 2009;54(24):2277-86
29. Fang B, Song Y. Treatment of severe therapy-resistant acute graft-versus-host disease with human adipose tissue-derived mesenchymal stem cells. Bone Marrow Transplant 2006;38(5):389-90
30. Weiss DJ, Casaburi R, Flannery R, et al. A placebo-controlled, randomized trial of mesenchymal stem cells in copd. Chest J 2013;143(6):1590-8
31. Asahara T, Murohara T, Sullivan A, et al. Isolation of putative progenitor endothelial cells for angiogenesis. Science 1997;275(5302):964-6
32. Zampetaki A, Kirton JP, Xu Q. Vascular repair by endothelial progenitor cells. Cardiovasc Res 2008;78(3):413-21
33. Yoon C-H, Hur J, Park K-W, et al. Synergistic neovascularization by mixed transplantation of early endothelial progenitor cells and late outgrowth endothelial cells. Circulation 2005;112(11):1618-27
34. Cheng-Chung C, Shing-Jyh C, Yu-Neng C, et al. Distinct angiogenesis roles and surface markers of early and late endothelial progenitor cells revealed by functional group analyses. BMC Genomics 2013;14(1):1-10
35. Wei J, Blum S, Unger M, et al. Embryonic endothelial progenitor cells armed with a suicide gene target hypoxic lung metastases after intravenous delivery. Cancer Cell 2004;5(5):477-88
36. Tsuchiya K, Hida K, Hida Y, et al. Adrenomedullin antagonist suppresses tumor formation in renal cell carcinoma through inhibitory effects on tumor endothelial cells and endothelial progenitor mobilization. Int J Oncol 2010;36(6):1379-86
37. Ceradini DJ, Kulkarni AR, Callaghan MJ, et al. Progenitor cell trafficking is regulated by hypoxic gradients through HIF-1 induction of SDF-1. Nat Med 2004;10(8):858-64
38. Rafat N, Hanusch C, Brinkkoetter PT, et al. Increased circulating endothelial progenitor cells in septic patients: Correlation with survival. Crit Care Med 2007;35(7):1677-84
39. Hill JM, Zalos G, Halcox JP, et al. Circulating endothelial progenitor cells, vascular function, and cardiovascular risk. N Engl J Med 2003;348(7):593-600
40. Dome B, Timar J, Dobos J, et al. Identification and clinical significance of circulating endothelial progenitor cells in human non-small cell lung cancer. Cancer Res 2006;66(14):7341-7
41. Burnham EL, Taylor WR, Quyyumi AA, et al. Increased circulating endothelial progenitor cells are associated with survival in acute lung injury. Am J Respir Crit Care Med 2005;172(7):854-60
42. Palange P, Testa U, Huertas A, et al. Circulating haemopoietic and endothelial progenitor cells are decreased in COPD. Eur Respir J 2006;27(3):529-41
43. Wang D, Morales JE, Calame DG, et al. Transplantation of human embryonic stem cell-derived alveolar epithelial type II cells abrogates acute lung injury in mice. Mol Ther 2010;18(3):625-34
44. Banerjee ER, Laflamme MA, Papayannopoulou T, et al. Human embryonic stem cells differentiated to lung lineage-specific cells ameliorate pulmonary fibrosis in a xenograft transplant mouse model. PLoS One 2012;7(3):e33165
45. Somers A, Jean JC, Sommer CA, et al. Generation of transgene-free lung disease-specific human induced pluripotent stem cells using a single excisable lentiviral stem cell cassette. Stem Cells 2010;28(10):1728-40
46. Yang K-Y, Shih H-C, How C-K, et al. IV delivery of induced pluripotent stem cells attenuates endotoxin-induced acute lung injury in mice. Chest J 2011;140(5):1243-53
47. Tiscornia G, Izpisua Belmonte JC. MicroRNAs in embryonic stem cell function and fate. Genes Dev 2010;24(24):2732-41
48. Bartel DP. MicroRNAs: Genomics, biogenesis, mechanism, and function. Cell 2004;116(2):281-97
49. Huang F, Fang ZF, Hu XQ, et al. Overexpression of mir-126 promotes the differentiation of mesenchymal stem cells toward endothelial cells via activation of pi3k/akt and mapk/erk pathways and release of paracrine factors. Biol Chem 2013;394(9):1223-33
50. Eskildsen T, Taipaleenmaki H, Stenvang J, et al. MicroRNA-138 regulates osteogenic differentiation of human stromal (mesenchymal) stem cells in vivo. Proc Natl Acad Sci USA 2011;108(15):6139-44
51. Zhang JF, Fu WM, He ML, et al. MiRNA-20a promotes osteogenic differentiation of human mesenchymal stem cells by co-regulating BMP signaling. RNA Biol 2011;8(5): 829-38
52. Katsuda T, Kosaka N, Takeshita F, Ochiya T. The therapeutic potential of mesenchymal stem cell-derived extracellular vesicles. Proteomics 2013;13(10-11):1637-53
53. Chen TS, Lai RC, Lee MM, et al. Mesenchymal stem cell secretes microparticles enriched in pre-microRNAs. Nucleic Acids Res 2010;38(1):215-24
54. Levanen B, Bhakta NR, Torregrosa Paredes P, et al. Altered microRNA profiles in bronchoalveolar lavage fluid exosomes in asthmatic patients. J Allergy Clin Immunol 2013;131(3):894-903
55. Miravitlles M, Soriano JB, Garcia-Rio F, et al. Prevalence of COPD in Spain: Impact of undiagnosed COPD on quality of life and daily life activities. Thorax 2009;64(10):863-8
56. Navaratnam V, Fleming K, West J, et al. The rising incidence of idiopathic pulmonary fibrosis in the UK. Thorax 2011;66(6):462-7
57. Faner R, Rojas M, MacNee W, Agustí A. Abnormal lung aging in chronic obstructive pulmonary disease and idiopathic pulmonary fibrosis. Am J Respir Crit Care Med 2012;186(4):306-13
58. Guillot PV, Gotherstrom C, Chan J, et al. Human first trimester fetal msc express pluripotency markers and grow faster and have longer telomeres than adult MSC. Stem Cells 2007;25(3):646-54
59. Mora AL, Rojas M. Aging and lung injury repair: A role for bone marrow derived mesenchymal stem cells. J Cell Biochem 2008;105(3):641-7
60. Conboy IM, Conboy MJ, Wagers AJ, et al. Rejuvenation of aged progenitor cells by exposure to a young systemic environment. Nature 2005;433(7027):760-4
61. Hermann A, List C, Habisch HJ, et al. Age-dependent neuroectodermal differentiation capacity of human mesenchymal stromal cells: Limitations for autologous cell replacement strategies. Cytotherapy 2010;12(1):17-30
62. Baxter MA, Wynn RF, Jowitt SN, et al. Study of telomere length reveals rapid aging of human marrow stromal cells following in vitro expansion. Stem Cells 2004;22(5):675-82
63. Huang K, Mitzner W, Rabold R, et al. Variation in senescent-dependent lung changes in inbred mouse strains. J Appl Physiol 2007;102(4):1632-9
64. Mays PK, Bishop JE, Laurent GJ. Age-related changes in the proportion of types I and III collagen. Mech Ageing Dev 1988;45(3):203-12
65. Burgess ML, McCrea JC, Hedrick HL. Age-associated changes in cardiac matrix and integrins. Mech Ageing Dev 2001;122(15):1739-56
66. Hocking DC. Fibronectin matrix deposition and cell contractilityimplications for airway remodeling in asthma. Chest J 2002;122(6-Suppl):275S-8S
67. Sueblinvong V, Neujahr DC, Mills ST, et al. Predisposition for disrepair in the aged lung. Am J Med Sci 2012;344(1):41-51
68. Muro AF, Moretti FA, Moore BB, et al. An essential role for fibronectin extra type III domain A in pulmonary fibrosis. Am J Respir Crit Care Med 2008;177(6):638-45
69. Strange C, Highland KB. Pulmonary hypertension in interstitial lung disease. Curr Opin Pulm Med 2005;11(5):452-5
70. Polomis D, Runo JR., Meyer KC. Pulmonary hypertension in interstitial lung disease. Curr Opin Pulm Med 2008;14(5):462-9
71. Yamashita T, Oda T, Sekimoto T. Fanconi anemia-genotoxic stress and senescence of hematopoietic stem cells. Nihon Rinsho 2008;66(3):477-82
72. Nalysnyk L, Cid-Ruzafa J, Rotella P, Esser D. Incidence and prevalence of idiopathic pulmonary fibrosis: Review of the literature. Eur Respir Rev 2012;21(126):355-61
73. Moeller A, Ask K, Warburton D, et al. The bleomycin animal model: A useful tool to investigate treatment options for idiopathic pulmonary fibrosis̈Int J Biochem Cell Biol 2008;40(3):362-82
74. Waghray M, Cui Z, Horowitz JC, et al. Hydrogen peroxide is a diffusible paracrine signal for the induction of epithelial cell death by activated myofibroblasts. Faseb J 2005;19(7):854-6
75. Yan X, Liu Y, Han Q, et al. Injured microenvironment directly guides the differentiation of engrafted Flk-1(+) mesenchymal stem cell in lung. Exp Hematol 2007;35(9):1466-75
76. Salazar KD, Lankford SM, Brody AR. Mesenchymal stem cells produce Wnt isoforms and TGF-beta1 that mediate proliferation and procollagen expression by lung fibroblasts. Am J Physiol Lung Cell Mol Physiol 2009;297(5):L1002-11
77. Hashimoto N, Jin H, Liu T, et al. Bone marrow-derived progenitor cells in pulmonary fibrosis. J Clin Invest 2004;113(2):243-52
78. Taraseviciene-Stewart L, Voelkel NF. Molecular pathogenesis of emphysema. J Clin Invest 2008;118(2):394-402
79. Murray CJ, Lopez AD. Alternative projections of mortality and disability by cause 1990-2020: Global burden of disease study. Lancet 1997;349(9064):1498- 504
80. Barbera JA, Peinado VI. Vascular progenitor cells in chronic obstructive pulmonary disease. Proc Am Thorac Soc 2011;8(6):528-34
81. Adcock IM, Caramori G, Barnes PJ. Chronic obstructive pulmonary disease and lung cancer: New molecular insights. Respiration 2011;81(4):265-84
82. Barnes PJ. Small airways in COPD. N Engl J Med 2004;350(26):2635-7
83. Schweitzer KS, Johnstone BH, Garrison J, et al. Adipose stem cell treatment in mice attenuates lung and systemic injury induced by cigarette smoking. Am J Respir Crit Care Med 2011;183(2):215-25
84. Katsha AM, Ohkouchi S, Xin H, et al. Paracrine factors of multipotent stromal cells ameliorate lung injury in an elastase-induced emphysema model. Mol Ther 2011;19(1):196-203
85. Weiss DJ, Casaburi R, Flannery R, et al. A placebo-controlled randomized trial of mesenchymal stem cells in chronic obstructive pulmonary disease. Chest 2013;143(6):1590-8
86. Asthma in the US. Vital Signs. 2011. Available from: Http://www.cdc. gov/vitalsigns/asthma/ [Cited May 2011]
87. Cho KS, Roh HJ. Immunomodulatory effects of adipose-derived stem cells in airway allergic diseases. Curr Stem Cell Res Ther 2010;5(2):111-15
88. Nemeth K, Keane-Myers A, Brown JM, et al. Bone marrow stromal cells use TGF-beta to suppress allergic responses in a mouse model of ragweed-induced asthma. Proc Natl Acad Sci USA 2010;107(12):5652-7
89. Park HK, Cho KS, Park HY, et al. Adipose-derived stromal cells inhibit allergic airway inflammation in mice. Stem Cells Dev 2010;19(11):1811-18
90. Bonfield TL, Koloze M, Lennon DP, et al. Human mesenchymal stem cells suppress chronic airway inflammation in the murine ovalbumin asthma model. Am J Physiol Lung Cell Mol Physiol 2010;299(6):L760-70
91. Gupta N, Su X, Popov B, et al. Intrapulmonary delivery of bone marrow-derived mesenchymal stem cells improves survival and attenuates endotoxin-induced acute lung injury in mice. J Immunol 2007;179(3):1855-63
92. Rubenfeld GD, Caldwell E, Peabody E, et al. Incidence and outcomes of acute lung injury. N Engl J Med 2005;353(16):1685-93
93. Xu J, Woods CR, Mora AL, et al. Prevention of endotoxin-induced systemic response by bone marrow-derived mesenchymal stem cells in mice. Am J Physiol Lung Cell Mol Physiol 2007;293(1):L131-L41
94. Mei SH, Haitsma JJ, Dos Santos CC, et al. Mesenchymal stem cells reduce inflammation while enhancing bacterial clearance and improving survival in sepsis. Am J Respir Crit Care Med 2010;182(8):1047-57
95. Rojas M, Parker RE, Thorn N, et al. Infusion of freshly isolated autologous bone marrow derived nuclear cells prevents endotoxin-induced lung injury in an ex-vivo perfused swine model. Stem Cell Res Ther 2013;4(2):26
96. Christie JD, Edwards LB, Kucheryavaya AY, et al. The registry of the international society for heart and lung transplantation: 29th adult lung and heart-lung transplant report-2012. JHeart Lung Transplant 2012;31(10):1073-86
97. Shi Q, Cao H, Liu J, et al. CD4 +Foxp3+regulatory T cells induced by TGF-b, IL-2 and all-trans retinoic acid attenuate obliterative bronchiolitis in rat trachea transplantation. Int Immunopharmacol 2011;11(11):1887-94
98. Grove DA, Xu J, Joodi R, et al. Attenuation of early airway obstruction by mesenchymal stem cells in a murine model of heterotopic tracheal transplantation. J Heart Lung Transplant 2011;30(3):341-50